{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:32Z","timestamp":1786988132198,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["1966\/2016"],"award-info":[{"award-number":["1966\/2016"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306082\/2014\u20134"],"award-info":[{"award-number":["306082\/2014\u20134"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejphar.2021.173953","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T21:23:52Z","timestamp":1613856232000},"page":"173953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Angiotensin II receptor type 1 blockade improves hyporesponsiveness to vasopressors in septic shock"],"prefix":"10.1016","volume":"897","author":[{"given":"Daniel","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Kramer","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-7062","authenticated-orcid":false,"given":"Regina","family":"Sordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7527-4370","authenticated-orcid":false,"given":"Karin","family":"Scheschowitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Campos","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Assreuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.173953_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biochi.2020.04.008","article-title":"Renin-angiotensin system at the heart of COVID-19 pandemic","volume":"174","author":"Alifano","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.ejphar.2021.173953_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2021.173953_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1542\/peds.107.1.36","article-title":"A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia","volume":"107","author":"Bilgin","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejphar.2021.173953_bib4","first-page":"715","article-title":"Plasma catecholamine levels and pulmonary dysfunction in sepsis","volume":"148","author":"Bocking","year":"1979","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.ejphar.2021.173953_bib47","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00003246-199810000-00018","article-title":"Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill","volume":"26","author":"Boldt","year":"1998","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2021.173953_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/1523-1747.ep12506462","article-title":"Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker","volume":"78","author":"Bradley","year":"1982","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2021.173953_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(92)90593-S","article-title":"Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier","volume":"219","author":"Bui","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.173953_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1159\/000107757","article-title":"From mitochondria to disease: role of the renin-angiotensin system","volume":"27","author":"de Cavanagh","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejphar.2021.173953_bib8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/bcp.12419","article-title":"Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis","volume":"78","author":"Dial","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.173953_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.03.011","article-title":"Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN","volume":"135","author":"Diniz","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.173953_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc8887","article-title":"Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis","volume":"14","author":"Doerschug","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2021.173953_bib11","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00134-003-1986-6","article-title":"Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure","volume":"29","author":"du Cheyron","year":"2003","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejphar.2021.173953_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0895-7061(00)00286-7","article-title":"In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan","volume":"13","author":"Fabiani","year":"2000","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2021.173953_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.ejphar.2021.173953_bib14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1124\/jpet.108.142034","article-title":"Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model","volume":"328","author":"Fernandes","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2021.173953_bib15","first-page":"1627","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Phys. Rev."},{"key":"10.1016\/j.ejphar.2021.173953_bib16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.173953_bib17","first-page":"7867","article-title":"Effects of angiotensin II type 1 receptor antagonist on rats with septic shock","volume":"8","author":"Guo","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.ejphar.2021.173953_bib46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS\u2010CoV\u20102 therapeutics","volume":"81","author":"Gurvitz","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2021.173953_bib18","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00134-009-1545-x","article-title":"Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats","volume":"35","author":"Hagiwara","year":"2009","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejphar.2021.173953_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/HYPERTENSIONAHA.119.13197","article-title":"Effect of renin-angiotensin-aldosterone system inhibitors on short-term mortality after sepsis: a population-based cohort study","volume":"75","author":"Hsu","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2021.173953_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ki.1991.249","article-title":"Angiotensin actions in the kidney: renewed insight into the old hormone","volume":"40","author":"Ichikawa","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2021.173953_bib21","first-page":"571","article-title":"Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats","volume":"56","author":"Kami\u0144ska","year":"2005","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.173953_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jinf.2017.08.012","article-title":"Adult sepsis \u2013 a nationwide study of trends and outcomes in a population of 23 million people","volume":"75","author":"Lee","year":"2017","journal-title":"J. Infect."},{"key":"10.1016\/j.ejphar.2021.173953_bib23","article-title":"Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis","author":"Lee","year":"2020","journal-title":"Kor. J. Intern. Med."},{"key":"10.1016\/j.ejphar.2021.173953_bib24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1164\/ajrccm.157.4.9705037","article-title":"Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction","volume":"157","author":"Levraut","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2021.173953_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0140-6736(20)32428-4","article-title":"Hypothesis SARS-CoV-2 and viral sepsis: observations and hypotheses","author":"Li","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.173953_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.abb.2008.09.019","article-title":"Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat","volume":"481","author":"Liu","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2021.173953_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"Norepinephrine: not too much, too long","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2021.173953_bib28","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1592\/phco.27.12.1619","article-title":"Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis","volume":"27","author":"Mortensen","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2021.173953_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.ejphar.2021.173953_bib30","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2021.173953_bib31","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.2215\/CJN.05480610","article-title":"Predictors of acute kidney injury in septic shock patients: an observational cohort study","volume":"6","author":"Plataki","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2021.173953_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.173953_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14728220903460332","article-title":"Modulation of the reninangiotensinaldosterone system in sepsis: a new therapeutic approach?","volume":"14","author":"Salgado","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2021.173953_bib34","first-page":"H1086","article-title":"Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia","volume":"249","author":"Schaller","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2021.173953_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phrs.2015.08.001","article-title":"Rapid NOS-1-derived nitric oxide and peroxynitrite formation act as signaling agents for inducible NOS-2 expression in vascular smooth muscle cells","volume":"100","author":"Scheschowitsch","year":"2015","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejphar.2021.173953_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/SHK.0b013e318189017a","article-title":"Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor\u03baB and mitogen-activated protein kinases","volume":"31","author":"Shen","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2021.173953_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.ejphar.2021.173953_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/iep.12016","article-title":"Pneumonia-induced sepsis in mice: temporal study of inflammatory and cardiovascular parameters","volume":"94","author":"Sordi","year":"2013","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2021.173953_bib39","first-page":"21","article-title":"Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury","volume":"41","author":"Suberviola","year":"2017","journal-title":"Med. Int."},{"key":"10.1016\/j.ejphar.2021.173953_bib40","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Angiotensin \u2013 aldosterone system inhibitors in patients with covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173953_bib41","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173953_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1291\/hypres.19.75","article-title":"Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats","volume":"19","author":"Wada","year":"1996","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2021.173953_bib43","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.RES.73.6.1121","article-title":"Metabolism and excretion of nitric oxide in humans: an experimental and clinical study","volume":"73","author":"Wennmalm","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.173953_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-4804(80)90037-2","article-title":"Sepsis and septic shock--a review of laboratory models and a proposal","volume":"29","author":"Wichterman","year":"1980","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2021.173953_bib45","first-page":"1260","article-title":"Modulation of angiotensin II-induced inflammatory cytokines by the Epac1-Rap1A-NHE3 pathway: implications in renal tubular pathobiology","volume":"306","author":"Xie","year":"2014","journal-title":"Am. J. Phys."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:47:50Z","timestamp":1757976470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921001060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":47,"alternative-id":["S0014299921001060"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173953","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II receptor type 1 blockade improves hyporesponsiveness to vasopressors in septic shock","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"173953"}}